US Map / Colorado
State CO

Clinical Trials in Colorado

Recruiting clinical trials with at least one study location in Colorado. Data updated daily from ClinicalTrials.gov.

Total Trials
264
Recruiting Now
264
← Back to US Map
Top Conditions in Colorado
Breast Cancer (6)Colorectal Cancer (6)Multiple Myeloma (5)Chronic Lymphocytic Leukemia (5)Advanced Solid Tumors (4)Depression (4)Small Lymphocytic Lymphoma (4)Non-small Cell Lung Cancer (3)Spinal Cord Injuries (3)Rheumatoid Arthritis (3)Asthma (3)Neuroblastoma (3)

Frequently Asked Questions — Clinical Trials in Colorado

How many clinical trials are currently recruiting in Colorado?
ClinicalMetric currently tracks 264 actively recruiting clinical trials with at least one location in Colorado. The total number of registered studies—including active but not currently enrolling trials—is 264. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Colorado?
Colorado hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Colorectal Cancer, Multiple Myeloma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Colorado serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Colorado?
To join a clinical trial in Colorado, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Colorado maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Colorado

NCT06623422 Phase 3
Recruiting
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
680 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT05410977 N/A
Recruiting
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neopl...
Condition
Colorectal Carcinoma
Enrollment
750 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT06561386 Phase 3
Recruiting
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs...
Condition
Non-small Cell Lung Cancer
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06016842 Phase 3
Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Chol...
Condition
Primary Biliary Cholangitis (PBC)
Enrollment
276 pts
Location
United States, Argentina, Australia
Sponsor
Ipsen
View Trial →
NCT06514794 Phase 2
Recruiting
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-C...
Condition
T-cell Acute Lymphoblastic Leukemia
Enrollment
125 pts
Location
United States, Australia
Sponsor
Wugen, Inc.
View Trial →
NCT06227377 Phase 1
Recruiting
QTX3034 in Patients With KRAS G12D Mutation
Condition
Solid Tumors
Enrollment
250 pts
Location
United States
Sponsor
Quanta Therapeutics
View Trial →
NCT06532279 Phase 2
Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the ...
Condition
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
98 pts
Location
United States
Sponsor
NRG Oncology
View Trial →
NCT03424005 Phase 1, Phase 2
Recruiting
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in...
Condition
Metastatic Breast Cancer
Enrollment
792 pts
Location
United States, Australia, France
Sponsor
Hoffmann-La Roche
View Trial →
NCT03821129 N/A
Recruiting
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reducti...
Condition
Stroke
Enrollment
636 pts
Location
United States
Sponsor
W.L.Gore & Associates
View Trial →
NCT06472245 Phase 3
Recruiting
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung...
Condition
Patients With Non-Small Cell Lung Cancer
Enrollment
363 pts
Location
United States, Belgium, Canada
Sponsor
OSE Immunotherapeutics
View Trial →
NCT07325266 Phase 2
Recruiting
Human Laboratory Study of Apremilast for Alcohol Use Disorder
Condition
Alcohol Use Disorder
Enrollment
100 pts
Location
United States
Sponsor
National Institute on Alcohol
View Trial →
NCT02915198 Phase 4
Recruiting
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuT...
Condition
Prediabetic State
Enrollment
7,410 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT06238492 N/A
Recruiting
A Pilot RCT to Improve Cognitive Processing Speed in Acute SCI
Condition
Spinal Cord Injuries
Enrollment
24 pts
Location
United States
Sponsor
Kessler Foundation
View Trial →
NCT07228117 N/A
Recruiting
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adult...
Condition
Type 1 Diabetes Mellitus
Enrollment
400 pts
Location
United States, Australia, New Zealand
Sponsor
Medtronic MiniMed, Inc.
View Trial →
NCT01185132 Phase 3
Recruiting
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Bre...
Condition
Breast Cancer
Enrollment
660 pts
Location
United States
Sponsor
Rocky Mountain Cancer Centers
View Trial →
NCT05594563 Phase 2
Recruiting
TArgeting Type 1 Diabetes Using POLyamines (TADPOL)
Condition
Type 1 Diabetes
Enrollment
81 pts
Location
United States
Sponsor
Emily K. Sims
View Trial →
NCT06433752 N/A
Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMV...
Condition
Relapsing Multiple Sclerosis
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
TG Therapeutics, Inc.
View Trial →
NCT05787821 N/A
Recruiting
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Condition
Knee Pain Chronic
Enrollment
760 pts
Location
United States
Sponsor
Zimmer Biomet
View Trial →
NCT04177914 Phase 3
Recruiting
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Condition
Hydrocephalus
Enrollment
176 pts
Location
United States, Canada
Sponsor
University of Utah
View Trial →
NCT06896916 Phase 1
Recruiting
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cerebl...
Condition
Multiple Myeloma
Enrollment
135 pts
Location
United States, Australia, Canada
Sponsor
AbbVie
View Trial →
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05535855 Phase 1
Recruiting
UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1
Condition
Acute Lymphoid Leukemia
Enrollment
29 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT05648591 Phase 4
Recruiting
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Condition
Schizophrenia
Enrollment
100 pts
Location
United States
Sponsor
Vanda Pharmaceuticals
View Trial →
NCT06770582 Phase 2
Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Ther...
Condition
Non-Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
160 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT03217006 N/A
Recruiting
Randomization of Single vs Multiple Arterial Grafts
Condition
Coronary Artery Disease
Enrollment
4,300 pts
Location
United States, Austria, Brazil
Sponsor
Weill Medical College of Corne
View Trial →
Page 1 of 11 — 264 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology